Latest filing published 01 Oct 2026 for Larimar Therapeutics, Inc..
Insider track record
No signal scores available.
John B. Harlow Jr.: trading record in brief
John B. Harlow Jr. discloses dealings in 2 companies, chiefly Esperion Therapeutics, Inc. and Larimar Therapeutics, Inc. Between 4 December 2025 and 29 September 2026, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 1 October 2026, the filings show a share grant in Larimar Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John B. Harlow Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Common StockSEC:0001193125-26-410719:0
- 424,536 sharesCommon StockSEC:0001628280-26-048003:0
- 424,536 shares0Common StockSEC:0001628280-25-055842:0
3 of 3 declarations
